University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

MoleculeDX Inc.

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Diagnostic

Therapeutic Areas

Oncology

Founders

Jian-Hua Luo

Website

https://www.moleculedx.com/
MoleculeDX Inc.

MoleculeDX brings molecular testing and machine learning together to support earlier detection of hepatocellular carcinoma, the most common form of primary liver cancer. Its Fusion-detect blood test analyzes cancer-associated fusion transcripts in serum and uses a computational model to identify patterns associated with the disease. At-home blood collection through contracted partners helps make testing more accessible. [1]

A University of Pittsburgh spinout, MoleculeDX builds on research into the molecular signals released by liver cancers. The company operates a CLIA-certified, COLA-accredited clinical laboratory and provides a digital platform for ordering tests, coordinating collection and receiving results, connecting laboratory innovation with practical screening support. [2] [3]

Discover More with AI